Switch to:
Valeant Pharmaceuticals International Inc (NYSE:VRX)
Cash And Cash Equivalents
$531 Mil (As of Jun. 2014)

Valeant Pharmaceuticals International Inc's quarterly cash and cash equivalents declined from Dec. 2013 ($600 Mil) to Mar. 2014 ($576 Mil) and declined from Mar. 2014 ($576 Mil) to Jun. 2014 ($531 Mil).

Valeant Pharmaceuticals International Inc's annual cash and cash equivalents increased from Dec. 2011 ($164 Mil) to Dec. 2012 ($916 Mil) but then declined from Dec. 2012 ($916 Mil) to Dec. 2013 ($600 Mil).


Cash and cash equivalents on banks book.

Historical Data

* All numbers are in millions except for per share data and ratio. All numbers are in their own currency.

Valeant Pharmaceuticals International Inc Annual Data

BS_CashAndCashEquivalents 34445835434318114394164916600

Valeant Pharmaceuticals International Inc Quarterly Data

BS_CashAndCashEquivalents 3303952589164142,539596600576531
Get WordPress Plugins for easy affiliate links on Stock Tickers and Guru Names | Earn affiliate commissions by embedding GuruFocus Charts
GuruFocus Affiliate Program: Earn up to $400 per referral. ( Learn More)
Free 7-day Trial